ASLAN003
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ASLAN003, covering 2016-11-02 to 2021-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia [Phase 2]